Elixir Medical Completes Enrollment of INFINITY-SWEDEHEART Clinical Trial
Largest randomized trial of DynamX Bioadaptor to date with 2,400 patients enrolled, covering real-world population
Source: dicardiology.com
Stay updated with breaking news from Device Oriented Clinical Endpoint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Largest randomized trial of DynamX Bioadaptor to date with 2,400 patients enrolled, covering real-world population